Work

How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary care.

Year: 2022

Type: article

Source: PubMed

Authors: Judd W Moul, Grannum R Sant

Institutions: Duke Medical Center, Tufts University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4292681658

FWCI: 0.765

Cites:

Cited by: 4

Related to: 10